- Home
- Publications
- Publication Search
- Publication Details
Title
From IgE to clinical trials of allergic rhinitis
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 11, Issue 12, Pages 1321-1333
Publisher
Informa UK Limited
Online
2015-11-07
DOI
10.1586/1744666x.2015.1086645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Specific Immunotherapy in Children: The Evidence
- (2017) M La Rosa et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- The discovery and development of omalizumab for the treatment of asthma
- (2015) Amelia Licari et al. Expert Opinion on Drug Discovery
- Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review
- (2015) Alain Didier et al. Expert Opinion On Drug Safety
- Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
- (2015) Cezmi A Akdis et al. World Allergy Organization Journal
- Allergic Rhinitis Phenotypes Based on Bronchial Hyperreactivity to Methacholine
- (2014) Giorgio Ciprandi et al. American Journal of Rhinology & Allergy
- Scientific Foundations of Allergen-Specific Immunotherapy for Allergic Disease
- (2014) Michael B Soyka et al. CHEST
- Modulation of immune responses by immunotherapy in allergic diseases
- (2014) Ozlem Cavkaytar et al. CURRENT OPINION IN PHARMACOLOGY
- Current recommendations and emerging options for the treatment of allergic rhinitis
- (2014) Amelia Licari et al. Expert Review of Clinical Immunology
- Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience
- (2014) Alain Didier et al. Expert Review of Clinical Immunology
- Oral/sublingualPhleum pretensegrass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA
- (2014) Harold S Nelson Expert Review of Clinical Immunology
- Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
- (2014) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in Children
- (2014) Amelia Licari et al. PEDIATRIC DRUGS
- Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2014) Sophia Tsabouri et al. Journal of Allergy and Clinical Immunology-In Practice
- Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?
- (2014) Harold S. Nelson Journal of Allergy and Clinical Immunology-In Practice
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update
- (2014) Giorgio Walter Canonica et al. World Allergy Organization Journal
- Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis
- (2013) K. Gangl et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy
- (2013) K. Aasbjerg et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Omalizumab for treatment of allergic rhinitis
- (2013) Priyanka Vashisht et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
- (2013) A. Wesley Burks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: A systematic review and indirect comparison
- (2013) Janine Dretzke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review
- (2013) J. M. Kim et al. PEDIATRICS
- How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area
- (2012) J. Sastre et al. ALLERGY
- Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons – The GRAAL Trial
- (2012) François Wessel et al. CLINICAL DRUG INVESTIGATION
- Recent Developments in United Airways Disease
- (2012) Giorgio Ciprandi et al. Allergy Asthma & Immunology Research
- Systematic reviews of sublingual immunotherapy (SLIT)
- (2011) S. Radulovic et al. ALLERGY
- Long-term clinical and immunological effects of allergen immunotherapy
- (2011) Aarif O. Eifan et al. Current Opinion in Allergy and Clinical Immunology
- T-cell responses during allergen-specific immunotherapy
- (2011) Enrico Maggi et al. Current Opinion in Allergy and Clinical Immunology
- Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
- (2011) Michael Blaiss et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
- (2011) Harold S. Nelson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies
- (2011) Louisa K. James et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergic rhinitis
- (2011) Alexander N Greiner et al. LANCET
- Responses of CD4+CD25+Foxp3+ and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children
- (2011) Wei Lou et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Comparison of allergen immunotherapy practice patterns in the United States and Europe
- (2010) Linda Cox et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma
- (2010) Gustavo J. Rodrigo et al. CHEST
- CD23/FcεRII: molecular multi-tasking
- (2010) M. Acharya et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
- (2010) Gian Enrico Senna et al. Expert Review of Clinical Immunology
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
- (2010) Jan L. Brożek et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of omalizumab on markers of inflammation in patients with allergic asthma
- (2009) S. Holgate et al. ALLERGY
- Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
- (2009) H-J. Malling et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
- (2009) F. Horak et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
- (2009) Albrecht Bufe et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously
- (2009) Wolfgang Kamin et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
- (2008) H. Ott et al. ALLERGY
- Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
- (2008) M. V. Kopp et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
- (2008) Gabrielle Pauli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years
- (2008) Ronald Dahl et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
- (2008) Ulrich Wahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started